Exclusive: 45% of GPs ignore NICE hypertension guidance

Only half of GPs are exclusively following the NICE/British Hypertension Society (BHS) guidelines issued in June this year, a GP survey has shown.

The survey of 238 GPs revealed that while 94 per cent had started to use the latest hypertension guidelines, 45 per cent applied them in conjunction with older recommendations, including the Joint British Societies’ guideline (JBS2) and previous BHS guidance.

It also showed that 9 per cent of those using a combination of guidelines referred to local protocols.

RCGP chairman Professor Mayur Lakhani criticised this mix-and-match approach, saying it compromised patient safety.
‘I would be concerned if inadvertent pressure was being put on GPs by primary care organisations (PCOs) to deviate from NICE guidance, which is the gold standard,’ he said. ‘A true translation of the NICE guidance by PCOs for local implementation could be workable but must not deviate from the evidence base.’ Hertfordshire GP Professor Mike Kirby, a member of the Primary Care Cardiovascular Society (PCCS), said it was unwise to use old guidelines ‘because medical evidence moves on’.

‘The risk is that people will go on to use beta-blockers first line and we know they’re less effective than other drugs,’ he said.

Evidence has shown that beta-blockers give less protection against stroke than other agents and, when used with diuretics, are associated with a 50 per cent increased risk of diabetes.

The NICE/BHS guideline puts beta-blockers fourth line for uncomplicated hypertension rather than first line as before. But the GP survey found that a fifth of GPs disagreed with this decision.

Leeds GP Dr Mark Davis, who was on the NICE/BHS guideline development group said: ‘Using a beta-blocker is better than nothing. It is encouraging that the majority are giving consideration to these guidelines.’

PCCS chairman and North Yorkshire GP Dr Terry McCormack welcomed the 94 per cent uptake and said using a combination of guidelines was to be expected: ‘A guideline is just that. The best way to use it is to adapt it.’

A spokesman for NICE said: ‘It is important to emphasise that the review of the NICE guideline was limited to the pharmacological aspects of hypertension. There- fore it is not surprising that GPs will use some other guidance.’


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Medical examiners to scrutinise deaths in community settings

The MDU's Dr Kathryn Leask explains how the expansion of the medical examiner system...

Person receiving a COVID-19 booster

COVID-19 booster campaign to start on 5 September, NHS England says

The COVID-19 booster programme will begin in care homes and for housebound patients...

GP consulting room

Nine in ten GPs fear their practice will struggle to cope this winter

Nearly nine in ten GPs fear that their practice will struggle to cope this winter,...

BMA sign

BMA elects new deputy chair of England GP committee and chair of Scottish council

Dr David Wrigley has been elected as new deputy chair of the BMA's GP committee in...

UK money

Almost half of practices say income from private fees has fallen in past year

Almost half of GP practices have seen their income from private and professional...

COVID-19 vaccination centre

BMA raises 'serious concerns' about GP workload and funding for autumn COVID boosters

The BMA has raised 'serious concerns' about the workload implications of this autumn's...